Zandile Nare currently works as a Senior Scientist in the CRO drug discovery space, exploring the intricate and complex relationships between molecules, targets, and cells. Her journey started with an MSc in Drug Discovery and Translational Biology from the University of Edinburgh, where she discovered an interest in target-based drug discovery, particularly for infectious diseases. This led her to pursue a PhD at the same university, focusing on drug discovery for African sleeping sickness and leishmaniases. Zandile is especially fascinated by protein engineering and integrative structural biology tools that push the boundaries of drug discovery.
Beyond the lab, Zandile enjoys helping scientists communicate their research effectively, aiming to bridge the gap between complex scientific concepts and diverse audiences. Whether it is through writing or research, Zandile’s ultimate goal is to contribute to a healthier world.
Eosinophil markers, including and CCR3, Siglec-F, IL-5Ra, ECP, MBP, are targeted by specific antibodies to characterize eosinophil localization and activation...
Monocyte markers such as CD14, CD16, CCR2, HLA-DR, and CX3CR1, are used to characterize and isolate monocytes in heterogeneous immune populations...